Compounds > gymnodimine a
Page last updated: 2024-11-12

gymnodimine a

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

gymnodimine A: macrocyclic imine phycotoxin produced by the dinoflagelate Karenia selliformis; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID11649137
CHEBI ID144404
MeSH IDM0569734

Synonyms (16)

Synonym
CHEBI:144404
(2s)-2-[(1r,2e,11r,16s,17e,19s,22r,24r)-19-hydroxy-2,15,18,24-tetramethyl-25-oxa-7-azatetracyclo[20.2.1.06,11.011,16]pentacosa-2,6,14,17-tetraen-14-yl]-4-methyl-2h-uran-5-one
hsdb 7754
(-)-gymnodimine
gym a
unii-7tv3j97it8
7tv3j97it8 ,
gymnodimine a
C20025
gym a [hsdb]
2(5h)-furanone, 3-methyl-5-(2,3,5,6,9,10,11,12,13,14,15,17a,20,21-tetradecahydro-15-hydroxy-8,10,16,18-tetramethyl-9,12-epoxy-1h-benzo(2,3)cyclohexadeca(1,2-b)pyridin-19-yl)-, (9r-(7e,9r*,10r*,12r*,15s*,16e,17as*,19(s*),21ar*))-
2(5h)-furanone, 3-methyl-5-((7e,9r,10r,12r,15s,16e,17as,21ar)-2,3,5,6,9,10,11,12,13,14,15,17a,20,21-tetradecahydro-15-hydroxy-8,10,16,18-tetramethyl-9,12-epoxy-1h-benzo(2,3)cyclohexadeca(1,2-b)pyridin-19-yl)-, (5s)-
2(5h)-furanone,3-methyl-5-[(7e,9r,10r,12r,15s,16e,17as,21ar)-2,3,5,6,9,10,11,12,13,14,15,17a,20,21-tetradecahydro-15-hydroxy-8,10,16,18-tetramethyl-9,12-epoxy-1h-benzo[2,3]cyclohexadeca[1,2-b]pyridin-
(5s)-5-[(4ar,8as,9e,11s,14r,16r,17r,18e)-11-hydroxy-8,10,16,18-tetramethyl-3,4,5,6,8a,11,12,13,14,15,16,17,20,21-tetradecahydro-2h-14,17-epoxybenzo[2,3]cyclohexadeca[1,2-b]pyridin-7-yl]-3-methylfuran-2(5h)-one
Q27268839
DTXSID60880103

Research Excerpts

Effects

ExcerptReferenceRelevance
"Gymnodimine A has been found in mollusks obtained along the whole northern coast of Spain from April 2017 to December 2019. "( Gymnodimine A in mollusks from the north Atlantic Coast of Spain: Prevalence, concentration, and relationship with spirolides.
Arévalo, F; Blanco, J; Correa, J; Lamas, JP; Moroño, Á; Rossignoli, AE, 2021)		3.51
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (60.00)24.3611
2020's2 (40.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.80

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.80 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.59 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.80)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
ConditionIndicatedRelationship StrengthStudiesTrials